Cite

    Somnath Bandyopadhyay et al.. “221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study.” Rheumatology, vol. 57, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095495725.0x000017